drugset / Trial / NCT00168337

A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular Edema

NCT00168337 ↗

Phase 3 Completed 554 enrolled Allergan
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will evaluate the safety and efficacy of an intravitreal implant of dexamethasone for the treatment of diabetic macular edema.

Timeline

Start
2005-05
Primary completion
2012-05
Completion
2012-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 350 ug Intravitreal
Subject Dexamethasone Small molecule 700 ug Intravitreal